Baxter International Financial Statements (BAX)
|
|
|
|
Report date
|
|
|
17.03.2020 |
11.02.2021 |
23.02.2022 |
09.02.2023 |
08.02.2024 |
|
12.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
11 362 |
11 673 |
12 784 |
15 113 |
14 813 |
|
13 988 |
|
Operating Income, bln rub |
|
|
976.0 |
603.0 |
779.0 |
-549.0 |
390.0 |
|
624.0 |
|
EBITDA, bln rub |
? |
|
1 870 |
2 536 |
2 519 |
-849.0 |
2 776 |
|
1 921 |
|
Net profit, bln rub |
? |
|
1 001 |
1 102 |
1 284 |
-2 421 |
2 656 |
|
108.0 |
|
|
OCF, bln rub |
? |
|
2 104 |
1 868 |
2 222 |
1 211 |
1 726 |
|
531.0 |
|
CAPEX, bln rub |
? |
|
696.0 |
709.0 |
743.0 |
679.0 |
692.0 |
|
504.0 |
|
FCF, bln rub |
? |
|
1 408 |
1 159 |
1 479 |
532.0 |
1 034 |
|
27.0 |
|
Dividend payout, bln rub
|
|
|
423.0 |
473.0 |
530.0 |
573.0 |
586.0 |
|
590.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
42.3% |
42.9% |
41.3% |
0.00% |
22.1% |
|
546.3% |
|
|
OPEX, bln rub |
|
|
3 885 |
2 971 |
3 395 |
4 528 |
5 272 |
|
4 195 |
|
Cost of production, bln rub |
|
|
6 601 |
7 086 |
7 679 |
9 716 |
9 838 |
|
8 704 |
|
R&D, bln rub |
|
|
595.0 |
521.0 |
534.0 |
605.0 |
667.0 |
|
634.0 |
|
Interest expenses, bln rub |
|
|
111.0 |
134.0 |
192.0 |
395.0 |
512.0 |
|
411.0 |
|
|
Assets, bln rub |
|
|
18 193 |
20 019 |
33 521 |
28 287 |
28 276 |
|
26 676 |
|
Net Assets, bln rub |
? |
|
7 882 |
8 689 |
9 077 |
5 833 |
8 402 |
|
7 872 |
|
Debt, bln rub |
|
|
5 961 |
6 804 |
18 310 |
17 213 |
14 364 |
|
13 194 |
|
Cash, bln rub |
|
|
3 335 |
3 730 |
2 951 |
1 718 |
3 194 |
|
1 420 |
|
Net debt, bln rub |
|
|
2 626 |
3 074 |
15 359 |
15 495 |
11 170 |
|
11 774 |
|
|
Ordinary share price, rub |
|
|
83.6 |
80.2 |
85.8 |
51.0 |
38.7 |
|
34.2 |
|
Number of ordinary shares, mln |
|
|
509.0 |
509.0 |
502.0 |
504.0 |
506.0 |
|
510.0 |
|
|
Market cap, bln rub |
|
|
42 563 |
40 842 |
43 092 |
25 689 |
19 562 |
|
17 442 |
|
EV, bln rub |
? |
|
45 189 |
43 916 |
58 451 |
41 184 |
30 732 |
|
29 216 |
|
Book value, bln rub |
|
|
3 381 |
3 801 |
-8 551 |
-7 803 |
-4 191 |
|
-3 360 |
|
|
EPS, rub |
? |
|
1.97 |
2.17 |
2.56 |
-4.80 |
5.25 |
|
0.21 |
|
FCF/share, rub |
|
|
2.77 |
2.28 |
2.95 |
1.06 |
2.04 |
|
0.05 |
|
BV/share, rub |
|
|
6.64 |
7.47 |
-17.0 |
-15.5 |
-8.28 |
|
-6.59 |
|
|
EBITDA margin, % |
? |
|
16.5% |
21.7% |
19.7% |
-5.62% |
18.7% |
|
13.7% |
|
Net margin, % |
? |
|
8.81% |
9.44% |
10.0% |
-16.0% |
17.9% |
|
0.77% |
|
FCF yield, % |
? |
|
3.31% |
2.84% |
3.43% |
2.07% |
5.29% |
|
0.15% |
|
ROE, % |
? |
|
12.7% |
12.7% |
14.1% |
-41.5% |
31.6% |
|
1.37% |
|
ROA, % |
? |
|
5.50% |
5.50% |
3.83% |
-8.56% |
9.39% |
|
0.40% |
|
|
P/E |
? |
|
42.5 |
37.1 |
33.6 |
-10.6 |
7.37 |
|
161.5 |
|
P/FCF |
|
|
30.2 |
35.2 |
29.1 |
48.3 |
18.9 |
|
646.0 |
|
P/S |
? |
|
3.75 |
3.50 |
3.37 |
1.70 |
1.32 |
|
1.25 |
|
P/BV |
? |
|
12.6 |
10.7 |
-5.04 |
-3.29 |
-4.67 |
|
-5.19 |
|
EV/EBITDA |
? |
|
24.2 |
17.3 |
23.2 |
-48.5 |
11.1 |
|
15.2 |
|
Debt/EBITDA |
|
|
1.40 |
1.21 |
6.10 |
-18.3 |
4.02 |
|
6.13 |
|
|
R&D/CAPEX, % |
|
|
85.5% |
73.5% |
71.9% |
89.1% |
96.4% |
|
125.8% |
|
|
CAPEX/Revenue, % |
|
|
6.13% |
6.07% |
5.81% |
4.49% |
4.67% |
|
3.60% |
|
| Baxter International shareholders |
